一種EGFR抑制劑的鹽、晶型及其用途

• 收藏
• 分享

专利权人:

Sunshine Lake Pharma Co.; Ltd.

发明人:

LIU, Bing,ZHANG, Weihong,ZHANG, Yingjun

申请号：

HK18113646

公开号：

HK1254666A1

申请日:

2018.10.24

申请国别(地区):

HK

年份:

2019

代理人:

摘要：

The invention relates to a salt, a hydrate or a crystalline form of an EGFR inhibitor, and use thereof. Specifically it relates to 4-[(3-chloro-4-fluorophenyl)amino]-7-methoxy-6-[3-[(1R,6S)-2,5-dioxa-8-azabicyclo [4.3.0] nonan-8-yl] propoxy] quinazoline dimethanesulfonate, hydrate and a crystalline form thereof； the invention also relates to a preparation method of the crystalline form disclosed herein, a pharmaceutical composition containing the crystalline form, and uses thereof for treating proliferative disorders.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/